Hester Biosciences Quarterly Results for Trading Insights

HESTERBIO • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹14 Cr
QSept 2025
Quarterly Results

Hester Biosciences Quarterly Results Key Highlights

  • Revenue of ₹83 Cr in Sept 2025 (+9.2% vs Mar 2025, -4.6% vs Sept 2024)
  • Net Profit of ₹14 Cr in Sept 2025 (+600.0% vs Mar 2025, +75.0% vs Sept 2024)
  • EBITDA of ₹24 Cr in Sept 2025 (+71.4% vs Mar 2025)
  • Operating Margin of 17.0% in Sept 2025 (-6.0pp vs Mar 2025)
  • Earnings Per Share of ₹16.85 in Sept 2025 (+825.8% vs Mar 2025)

Hester Biosciences Quarterly Results Analysis

Metric Sept 2025 Mar 2025 Jun 2025 Dec 2025 Sept 2024 QoQ YoY
Revenue (₹ Cr) 83 76 88 79 87 9.2% -4.6%
Net Profit (₹ Cr) 14 2 17 9 8 - -
EBITDA (₹ Cr) 24 14 26 20 22 - -
EPS (₹) 16.85 1.82 20.33 10.94 9.86 - -
Operating Margin (%) 17.0% 23.0% 27.0% 23.0% 23.0% - -

Hester Biosciences Share Price Trend Around Quarterly Results

Visualize Hester Biosciences's 1-year price movement across quarterly results — ideal for logging trades in Tickjournal. All values in ₹.

Related Pages for Hester Biosciences

Additional stock information and data for HESTERBIO

HESTERBIO stock live price
HESTERBIO price earnings ratio
HESTERBIO 52-week high low

Profitability Ratios

Profit Margin 16.9%
EBITDA Margin 28.9%
Operating Margin 17.0%
ROE (Annual) 17.1%

Balance Sheet Highlights

Total Assets ₹653 Cr
Total Equity ₹327 Cr
Current Assets ₹195 Cr
Current Liabilities ₹202 Cr

Cash Flow Analysis

Operating Cash Flow ₹65 Cr
Investing Cash Flow ₹-20 Cr
Financing Cash Flow ₹-52 Cr
Net Cash Flow ₹-7 Cr

Current Market Data

Current Price ₹1423.70
Exchange NSE
Last Updated Apr 08, 2026

Revenue Trend (₹ Cr)

Dec 2025 79
Jun 2025 88
Mar 2025 76
Sept 2025 83

Net Profit Trend (₹ Cr)

Dec 2025 9
Jun 2025 17
Mar 2025 2
Sept 2025 14

Operating Margin Trend (%)

Dec 2025 23.0%
Jun 2025 27.0%
Mar 2025 23.0%
Sept 2025 17.0%

Sector Competitors - Quarterly Performance Comparison

Comparing Hester Biosciences quarterly results with other companies in Healthcare sector
Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025 		₹406,351.37 Cr 1714.6 14,875 3,125 +10.8% - 21.0% 131.9
Divis Laboratories
Sept 2025 		₹155,471.67 Cr 5882.0 2,860 689 +7.1% - 24.1% 226.5
Torrent Pharmaceuti…
Sept 2025 		₹134,945.00 Cr 4029.2 3,219 591 +11.3% - 18.4% 229.7
Lupin
Sept 2025 		₹102,578.78 Cr 2294.1 6,921 1,485 +23.2% - 21.5% 70.9
Dr Reddys Laborator…
Sept 2025 		₹101,601.09 Cr 1191.4 9,135 1,337 +1.1% - 14.6% 73.6
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores